Skip to content
Search

Latest Stories

Raylane Pharmacy Group expands portfolio; father-son duo buys Wards Chemist

Raylane Pharmacy Group expands portfolio; father-son duo buys Wards Chemist

Evans Pharmacy in Worcestershire and Wards Chemist in Birmingham have found new owners

Raylane Pharmacy Group has expanded its portfolio by acquiring Evans Pharmacy in Worcestershire. With this new addition, the independent community pharmacy chain has increased its total number of branches to 10.

Located in the centre of Malvern Link in Worcestershire, Evans Pharmacy dispenses approximately 10,000 items per month.


The acquisition follows the retirement of the previous owner, Philip Hawkes, who had managed the business for over a decade.

The sale was facilitated by Christie and Co through a confidential process, and the transaction price remains undisclosed.

Commenting on the deal, Carl Steer, director-pharmacy at Christie and Co, said: “The sale represents a perfect addition to an already successful group for Raylane Ltd.

“The instruction proved popular, and the completion represents another sale for Christie and Co in a record year for pharmacy sales.”

Raylane Pharmacy Group operates across the West Midlands and South West. Its existing branches include:

  1. Bills Pharmacy, Kinver, Staffordshire
  2. Central Pharmacy, Wolverhampton West Midlands
  3. Claines Pharmacy & Travel Vaccines Clinic, Worcester, Worcestershire
  4. Hawne Chemist & Travel Vaccines Clinic, Halesowen, West Midlands
  5. James Pharmacy & Travel Vaccines Clinic, Cheltenham, Gloucestershire
  6. Millard & Bullock Pharmacy, Coseley, West Midlands
  7. St Marks Pharmacy, Cheltenham, Gloucestershire
  8. Tividale Pharmacy, Rowley Regis, West Midlands
  9. Wymans Brook Pharmacy & Travel Vaccines Clinic, Cheltenham, Gloucestershire

The broker has also announced the sale of Wards Chemist in Birmingham, acquired by father-and-son duo Ian and Jas Riaar, who already own Yew Tree Pharmacy in Walsall.

Wards Chemist, located in the village of Handsworth Wood, a suburb of North Birmingham, dispenses an average of 6,613 items per month.

Diane Scott, the previous owner who managed the pharmacy for nearly 10 years, decided to sell the business upon her retirement.

Carl Steer, who oversaw the sales process, said:“After many months of back and forth with potential private sales, Mrs Scott instructed us and quickly we placed the pharmacy under offer, after receiving multiple acceptable offers.”

This is the second pharmacy the Riaar family has purchased through Christie and Co, having previously acquired their Walsall pharmacy via the broker.

Steer revealed that the family is already in the process of adding a third pharmacy.

“It was also pleasing to sell another pharmacy to the Riaar family, a lovely family that already has a third pharmacy purchase in the pipeline,” he stated.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less